Skip to main content

Table 3 Worst toxicity grade by patient during all cycles of treatment with the FOLFOX/BEVACIZUMAB combination

From: Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

 

Grade

       
 

1

2

3

4

 

n

%

n

%

n

%

n

%

Neutropenia

4

7.5

10

18.9

6

11.3

2

3.8

Febrile neutropenia

-

-

-

-

1

1.9

-

-

Anemia

39

73.6

5

9.4

1

1.9

-

-

Thrombocytopenia

8

15.1

2

3.8

1

1.9

-

-

Nausea

6

11.3

1

1.9

1

1.9

-

-

Vomiting

4

7.5

2

3.8

-

-

-

-

Diarrhea

10

18.9

7

13.2

4

7.6

-

-

Mucocitis

3

5.7

-

-

-

-

-

-

Constipation

9

17.0

3

5.7

-

-

-

-

Neurotoxicity

18

33.9

9

16.9

8

15.1

-

-

Alopecia

12

22.6

2

3.8

-

-

-

-

Fatigue

13

24.5

6

11.3

-

-

-

-

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us